PARIS–(BUSINESS WIRE)–Regulatory News: Disclaimer: Intended for international media and investor audiences only Ipsen (Euronext: IPN; ADR: IPSEY) today announced the closing of the definitive merger agreement under which Ipsen has acquired Epizyme, Inc. (Epizyme). Pursuant to the transaction, Ipsen acquires all outstanding shares of Epizyme for $1.45 per share plus a contingent value right (CVR) … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Anesthesia and Respiratory Devices: Global Markets” report has been added to ResearchAndMarkets.com’s offering. This report includes corporate-level profiles of key companies in the anesthesia and respiratory devices market that operate in the United States and other key countries, including a brief overview of each company, its business activities, and its hold or presence … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Opioids Market (2022-2027) by Product Type, Receptor Binding, Application, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Opioids Market is estimated to be USD 5.1 Bn in 2022 and is expected to reach USD 6.29 Bn by 2027, growing at … [Read more…]
Confluent Medical Technologies Announces the Grand Opening of the Newest Building at Their Large Scale Manufacturing Center of Excellence in Alajuela, Costa Rica SCOTTSDALE, Ariz.–(BUSINESS WIRE)–#Catheter–Confluent Medical Technologies (Confluent), today announced the Grand Opening of the latest addition to their large scale manufacturing center of excellence in Alajuela, Costa Rica, expanding their capacity for Nitinol … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Virtual Clinical Trials Global Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global virtual clinical trials market is expected to grow from $8.85 billion in 2021 to $9.61 billion in 2022 at a compound annual growth rate (CAGR) of 8.68%. The virtual clinical trials market is expected to grow to … [Read more…]
MANHASSET, N.Y.–(BUSINESS WIRE)–Terrorism, acts of war, nuclear power plant malfunctions; the risk of massive radiation exposure is ever-present. Scientists from The Feinstein Institutes for Medical Research have been awarded a five-year, $3.8 million grant from the National Institutes of Health (NIH) to study how radiation affects the human body’s immune system and how to better … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2035” report has been added to ResearchAndMarkets.com’s offering. Animal Testing The global animal testing market was valued at $10.74 billion in 2019 and the market is expected to grow at a compound annual growth rate (CAGR) of 4.27% during 2019-2025 and … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “In Vitro Diagnostics Market by Product & Service, Technique, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. At an estimated value of over USD 86.51 billion in 2021, the Global In Vitro Diagnostics (IVD) Market is predicted to thrive at a … [Read more…]
READING, England–(BUSINESS WIRE)–Sanofi (EURONEXT: SAN and NASDAQ: SNY) and the National Institute for Health and Care Research (NIHR) have today announced that the first patient has been enrolled in the Hospitalised RSV Monoclonal Antibody Prevention (HARMONIE) study. The large European interventional clinical study is investigating protection against Respiratory syncytial virus (RSV) in infants. HARMONIE is … [Read more…]
Phase III Clinical Stage Company Demonstrates Superior Efficacy of Proprietary Stem Cell Apoptotic Body Based Drug ELK CITY, Idaho–(BUSINESS WIRE)–Therapeutic Solutions International announced today new data demonstrating superior effects of the Company’s ApoptoCyte™ procedure treated JadiCell™ product compared to other stem cells in treating an animal model of Chronic Obstructive Pulmonary Disease (COPD). In a … [Read more…]
